Finance

Lists
Why is SKYE down २.५२%?
Dive Deeper
SKYE:NASDAQ
Skye Bioscience Inc
US$ १.५५
-२.५२%
(-०.०४०) 1D
US$ १.५५
०.००% (०.००)
After hours
Closed: अक्टोबर १६, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SKYE...
Open
US$ १.६०
High
US$ १.६०
Low
US$ १.५४
Mkt. cap
६८.६३ लाख
Avg. vol.
६५.३४ हजार
Volume
२०.२० हजार
52-wk high
US$ १३.२८
52-wk low
US$ १.५०
EPS
-US$ १०.१८
Beta
२.८६
Shares outstanding
४४.२८ लाख
No. of employees
२
Open
US$ १.६०
High
US$ १.६०
Low
US$ १.५४
Mkt. cap
६८.६३ लाख
Avg. vol.
६५.३४ हजार
Volume
२०.२० हजार
52-wk high
US$ १३.२८
52-wk low
US$ १.५०
EPS
-US$ १०.१८
Beta
२.८६
Shares outstanding
४४.२८ लाख
No. of employees
२
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
४ घण्टा पहिले
Understanding Momentum Shifts in (AGIX)
MarketBeat
MarketBeat
·
१९ मिनेट पहिले
Scholastic (NASDAQ:SCHL) Raised to Hold at Wall Street Zen
About Skye Bioscience Inc
CEO-
Employees२
Founded२०११
Headquarters-
Sector-
Analyst
Recommendation
Action
Price target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Maintained
US$ २०.००
+१,१९०.३%
05/21/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
US$ ६.००
+२८७.१%
05/12/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
05/12/2026
Jay Olson
Oppenheimer
Buy
Maintained
US$ १०.००
+५४५.२%
03/11/2026
Kristen Kluska
Cantor Fitzgerald
Hold
Maintained
US$ २.००
+२९%
03/10/2026
Albert Lowe
Craig-Hallum
Hold
Maintained
-
-
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
९३.५७ लाख
१.१५ करोड
७९.३६ लाख
३९.४२ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३९.०७ लाख
३४.२६ लाख
४७.३९ लाख
३८.६९ लाख
Operating expense
१.३३ करोड
१.४९ करोड
१.२७ करोड
७८.११ लाख
Total operating expenses
१.३३ करोड
१.४९ करोड
१.२७ करोड
७८.११ लाख
Operating income
-१.३३ करोड
-१.४९ करोड
-१.२७ करोड
-७८.११ लाख
Other non operating income
-
-५०२.००
-२.४१ हजार
-
EBT including unusual items
-१.२८ करोड
-१.४४ करोड
-१.२५ करोड
-१.०८ करोड
EBT excluding unusual items
-१.२८ करोड
-१.४६ करोड
-१.२५ करोड
-७७.११ लाख
Income tax expense
-
-
-
३.४० हजार
Effective tax rate
-
-
-
-०.०३%
Other operating expenses
-
-
-
-
Net income
-१.२८ करोड
-१.४४ करोड
-१.२५ करोड
-१.०८ करोड
Net profit margin
-
-
-
-
Earnings per share
-२.५९
-२.९५
-२.५६
-१.५५
Interest and investment income
४.१८ लाख
२.७४ लाख
१.७० लाख
१.०३ लाख
Interest expense
-
-
-२.२० हजार
-३.३० हजार
Net interest expenses
४.१८ लाख
२.७४ लाख
१.६७ लाख
९९.९१ हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.३१ करोड
-१.४७ करोड
-१.२५ करोड
-७६.५४ लाख
Gain or loss from assets sale
-९१.४० हजार
-१.८० लाख
७.६२ हजार
४.११ लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू